Epigenetics, Microbiota, and Breast Cancer: A Systematic Review
Metadatos
Afficher la notice complèteEditorial
MDPI
Materia
Breast cancer Epigenetic Microbiota
Date
2024-05-30Referencia bibliográfica
Soldado-Gordillo, A.; Álvarez-Mercado, A.I. Epigenetics, Microbiota, and Breast Cancer: A Systematic Review. Life 2024, 14, 705. https://doi.org/10.3390/life14060705
Résumé
Breast cancer is the most frequently diagnosed cancer in women worldwide. According
to recent studies, alterations in the microbiota and epigenetic modulations are risk factors for this
disease. This systematic review aims to determine the possible associations between the intestinal
and mammary microbial populations, epigenetic modifications, and breast cancer. To achieve this
objective, we conducted a literature search in the PubMed, Web of Science, and Science Direct
databases following the PRISMA guidelines. Although no results are yet available in humans, studies
in mice suggest a protective effect of maternal dietary interventions with bioactive compounds on
the development of breast tumors in offspring. These dietary interventions also modified the gut
microbiota, increasing the relative abundance of short-chain fatty acid-producing taxa and preventing
mammary carcinogenesis. In addition, short-chain fatty acids produced by the microbiota act as
epigenetic modulators. Furthermore, some authors indicate that stress alters the gut microbiota,
promoting breast tumor growth through epigenetic and gene expression changes in the breast tumor
microenvironment. Taken together, these findings show the ability of epigenetic modifications and
alterations of the microbiota associated with environmental factors to modulate the development,
aggressiveness, and progression of breast cancer.